Panel Discussion – Key Considerations in Gene Therapy Manufacturing for Commercialization – Please Submit Questions

We are excited at Cell Culture Dish to be chairing a panel discussion at next week’s Cell and Gene Therapy Bioprocessing and Commercialization Conference. The panel titled, Key Considerations in Gene Therapy Manufacturing for Commercialization, will focus on gene therapy manufacturing, including the latest in manufacturing methods, analytical analysis and key regulatory considerations. Topics to be discussed include:

  • Planning for scale up, technology transfer and regulatory considerations on the way to commercialization.
  • In-house vs. Outsourcing manufacturing.
  • Ensuring scalability and efficient timelines in manufacturing while still maintaining reasonable cost.
  • Analytical Development
  • Where are we at as an industry and where is there room for improvement.

Panel members include:

Brandy SargentEditor, Cell Culture Dish, USA

Nina ForsbergMarketing Director, Vironova, Sweden

Clive GloverSenior Global Marketing Manager, Pall, United Kingdom

John MadsenHead, Process Development Operations, Fujifilm Diosynth Biotechnologies, USA

Tracy TreDenickHead of Regulatory and Quality Assurance, Founding Partner, BioTechLogic, USA

Ross VerheulSenior Application Scientist, Beckman Coulter Life Sciences, USA

Joe HughesChief Scientist, VP Process and Analytical Development, WuXi Advanced Therapies

Pratik Jaluria – Executive Director of the Process Development & Manufacturing Group, Adverum Biotechnologies

Can’t make it in person? In addition to questions from the audience, we would also like to include questions from our readers. We will be publishing an audio recording of the panel as a podcast after the event.

Please submit your questions using the form below, we look forward to hearing from you.